首页|普瑞巴林治疗卒中后中枢痛患者的效果

普瑞巴林治疗卒中后中枢痛患者的效果

扫码查看
目的:分析普瑞巴林治疗卒中后中枢痛患者的效果。方法:选择本院2021年5月—2023年5月收治的80例卒中后中枢痛患者,随机分为对照组和观察组,每组40例。对照组实施奥氮平治疗,观察组实施普瑞巴林治疗,比较两组神经递质指标[5-羟色胺(5-HT)、多巴胺(DA)、去甲肾上腺素(NE)]、NRS评分、PSQI评分、HAMD评分、HAMA评分。结果:治疗后,观察组5-HT、DA、NE优于对照组(P<0。05);观察组NRS疼痛评分、PSQI评分、HAMD评分、HAMA评分低于对照组(P<0。05)。结论:普瑞巴林能进一步改善卒中后中枢痛患者的神经递质,减轻疼痛程度,有利于睡眠质量的改善,值得临床应用。
Effect of Pregabalin in the Treatment of Patients with Central Pain After Stroke
Objective:To analyze the effect of pregabalin in the treatment of patients with central pain after stroke. Methods:A total of 80 patients with post-stroke central pain admitted to our hospital from March 2021 to July 2023 were randomly divided into control group and observation group,with 40 patients in each group. The control group was treated with olanzapine,and the observation group was treated with pregabalin. The neurotransmitter indexes[5-hydroxytryptamine (5-HT),dopamine (DA),norepinephrine (NE)],NRS score,PSQI score,HAMD score and HAMA score were compared between the two groups. Results:After treatment,5-HT,DA and NE in the observation group were better than those in the control group (P<0.05). The NRS pain score,PSQI score,HAMD score and HAMA score of the observation group were lower than those of the control group (P<0.05). Conclusion:Pregabalin can further improve the neurotransmitters in patients with post-stroke central pain,reduce the degree of pain,and is conducive to the improvement of sleep quality,which is worthy of clinical application.

PrebarinCentral pain after strokeNeurotransmitterSleep structure

李琳、吴金栋、赖小燕

展开 >

福建中医药大学附属第三人民医院西药房,福建福州 350108

普瑞巴林 卒中后中枢痛 神经递质 睡眠结构

2024

中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
年,卷(期):2024.30(11)